205 related articles for article (PubMed ID: 32903592)
1. Significant Prognostic Value of the Autophagy-Related Gene P4HB in Bladder Urothelial Carcinoma.
Lyu L; Xiang W; Zheng F; Huang T; Feng Y; Yuan J; Zhang C
Front Oncol; 2020; 10():1613. PubMed ID: 32903592
[TBL] [Abstract][Full Text] [Related]
2. P4HB: A novel diagnostic and prognostic biomarker for bladder carcinoma.
Wu Y; Peng Y; Guan B; He A; Yang K; He S; Gong Y; Li X; Zhou L
Oncol Lett; 2021 Feb; 21(2):95. PubMed ID: 33376528
[TBL] [Abstract][Full Text] [Related]
3. Autophagy-related gene
Xie L; Li H; Zhang L; Ma X; Dang Y; Guo J; Liu J; Ge L; Nan F; Dong H; Yan Z; Guo X
Aging (Albany NY); 2020 Jan; 12(2):1828-1842. PubMed ID: 32003756
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of hypoxia-inducible factor-1 alpha and prolyl 4-hydroxylase beta polypeptide overexpression in gastric cancer.
Zhang J; Wu Y; Lin YH; Guo S; Ning PF; Zheng ZC; Wang Y; Zhao Y
World J Gastroenterol; 2018 Jun; 24(22):2381-2391. PubMed ID: 29904245
[TBL] [Abstract][Full Text] [Related]
5. Targeted Inhibition of P4HB Promotes Cell Sensitivity to Gemcitabine in Urothelial Carcinoma of the Bladder.
Wang X; Bai Y; Zhang F; Yang Y; Feng D; Li A; Yang Z; Li D; Tang Y; Wei X; Wei W; Han P
Onco Targets Ther; 2020; 13():9543-9558. PubMed ID: 33061438
[TBL] [Abstract][Full Text] [Related]
6. Development of an autophagy-related gene expression signature for prognosis prediction in prostate cancer patients.
Hu D; Jiang L; Luo S; Zhao X; Hu H; Zhao G; Tang W
J Transl Med; 2020 Apr; 18(1):160. PubMed ID: 32264916
[TBL] [Abstract][Full Text] [Related]
7. Deciphering the immunological and prognostic features of bladder cancer through platinum-resistance-related genes analysis and identifying potential therapeutic target P4HB.
Xiong S; Li S; Zeng J; Nie J; Liu T; Liu X; Chen L; Fu B; Deng J; Xu S
Front Immunol; 2023; 14():1253586. PubMed ID: 37790935
[TBL] [Abstract][Full Text] [Related]
8. A meta-analysis and bioinformatics analysis of P4HB expression levels in the prognosis of cancer patients.
Wang F; Yu Z; Liu X; Hu F; Liu X; Fu X; Liu Y; Zou Z
Pathol Res Pract; 2023 May; 245():154474. PubMed ID: 37119730
[TBL] [Abstract][Full Text] [Related]
9. Solute carrier family 12 member 5 promotes tumor invasion/metastasis of bladder urothelial carcinoma by enhancing NF-κB/MMP-7 signaling pathway.
Liu JY; Dai YB; Li X; Cao K; Xie D; Tong ZT; Long Z; Xiao H; Chen MK; Ye YL; Liu B; Tan J; Tang J; Xu ZZ; Gan Y; Zhou YH; Deng F; He LY
Cell Death Dis; 2017 Mar; 8(3):e2691. PubMed ID: 28333147
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of P4HB is correlated with poor prognosis in human clear cell renal cell carcinoma.
Zhu Z; He A; Lv T; Xu C; Lin L; Lin J
Cancer Biomark; 2019; 26(4):431-439. PubMed ID: 31640086
[TBL] [Abstract][Full Text] [Related]
11. Identification of an 11-Autophagy-Related-Gene Signature as Promising Prognostic Biomarker for Bladder Cancer Patients.
Zhou C; Li AH; Liu S; Sun H
Biology (Basel); 2021 Apr; 10(5):. PubMed ID: 33925460
[TBL] [Abstract][Full Text] [Related]
12. Genome-Wide Identification of Autophagy Prognostic Signature in Pancreatic Cancer.
Yu J; Lang Q; Zhong C; Wang S; Tian Y
Dose Response; 2021; 19(2):15593258211023260. PubMed ID: 34262410
[TBL] [Abstract][Full Text] [Related]
13. Immune Checkpoint Human Endogenous Retrovirus-H Long Terminal Repeat-Associating Protein 2 is Upregulated and Independently Predicts Unfavorable Prognosis in Bladder Urothelial Carcinoma.
Lin G; Ye H; Wang J; Chen S; Chen X; Zhang C
Nephron; 2019; 141(4):256-264. PubMed ID: 30602154
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of REDD1 Sensitizes Bladder Urothelial Carcinoma to Paclitaxel by Inhibiting Autophagy.
Zeng Q; Liu J; Cao P; Li J; Liu X; Fan X; Liu L; Cheng Y; Xiong W; Li J; Bo H; Zhu Y; Yang F; Hu J; Zhou M; Zhou Y; Zou Q; Zhou J; Cao K
Clin Cancer Res; 2018 Jan; 24(2):445-459. PubMed ID: 29084921
[No Abstract] [Full Text] [Related]
15. Overexpression of high mobility group box 1 contributes to progressive clinicopathological features and poor prognosis of human bladder urothelial carcinoma.
Huang C; Huang Z; Zhao X; Wang Y; Zhao H; Zhong Z; Wang L
Onco Targets Ther; 2018; 11():2111-2120. PubMed ID: 29695918
[TBL] [Abstract][Full Text] [Related]
16. Endoplasmic reticulum chaperone prolyl 4-hydroxylase, beta polypeptide (P4HB) promotes malignant phenotypes in glioma via MAPK signaling.
Sun S; Kiang KMY; Ho ASW; Lee D; Poon MW; Xu FF; Pu JKS; Kan ANC; Lee NPY; Liu XB; Man K; Day PJR; Lui WM; Fung CF; Leung GKK
Oncotarget; 2017 Sep; 8(42):71911-71923. PubMed ID: 29069756
[TBL] [Abstract][Full Text] [Related]
17. Development of a Prognostic Signature Based on Autophagy-related Genes for Head and Neck Squamous Cell Carcinoma.
Jin Y; Qin X
Arch Med Res; 2020 Nov; 51(8):860-867. PubMed ID: 32948377
[TBL] [Abstract][Full Text] [Related]
18. Identification of key pathways and genes influencing prognosis in bladder urothelial carcinoma.
Ning X; Deng Y
Onco Targets Ther; 2017; 10():1673-1686. PubMed ID: 28356754
[TBL] [Abstract][Full Text] [Related]
19. High PRMT5 expression is associated with poor overall survival and tumor progression in bladder cancer.
Tan L; Xiao K; Ye Y; Liang H; Chen M; Luo J; Qin Z
Aging (Albany NY); 2020 May; 12(9):8728-8741. PubMed ID: 32392182
[TBL] [Abstract][Full Text] [Related]
20. Prolyl 4-hydroxylase subunit beta (P4HB) could serve as a prognostic and radiosensitivity biomarker for prostate cancer patients.
Feng D; Li L; Li D; Wu R; Zhu W; Wang J; Ye L; Han P
Eur J Med Res; 2023 Jul; 28(1):245. PubMed ID: 37480146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
